SUMMIT THERAPEUTICS PLC's ticker is SMMT and the CUSIP is 86627R102. A total of 21 filers reported holding SUMMIT THERAPEUTICS PLC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 212,018 | $2,349,000 | 0.28% |
| Granite Point Capital Management, L.P. | 242,113 | $2,683,000 | 0.26% |
| LANSDOWNE PARTNERS (UK) LLP | 1,596,666 | $17,691,000 | 0.16% |
| Point72 Asset Management, L.P. | 785,600 | $8,704,000 | 0.04% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 80,000 | $886,000 | 0.02% |
| AXA S.A. | 282,760 | $3,133,000 | 0.01% |
| Polar Capital LLP | 100,000 | $1,108,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 144,083 | $1,595,000 | 0.01% |
| First Eagle Investment Management, LLC | 194,900 | $2,159,000 | 0.01% |
| Alyeska Investment Group, L.P. | 50,000 | $554,000 | 0.00% |